| 11. | Mutations are especially prevalent in clear cell renal cell carcinoma.
|
| 12. | It hadn't worked; it rarely does for renal cell carcinoma.
|
| 13. | Type 2 has also been further subdivided based on risks of renal cell carcinoma.
|
| 14. | Most renal cell carcinomas occur in adults between the ages of 50 and 70.
|
| 15. | Rarely, it is associated with clear cell renal cell carcinoma and papillary renal cell carcinoma.
|
| 16. | Vorsetuzumab mafodotin is a CD70-targeted antibody-drug conjugate that started clinical trials for renal cell carcinoma.
|
| 17. | Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas.
|
| 18. | Rarely, it is associated with clear cell renal cell carcinoma and papillary renal cell carcinoma.
|
| 19. | Treatment of renal cell carcinoma with infliximab resulted in prolonged disease stabilization in certain patients.
|
| 20. | Prostate cancer, germ cell cancer and renal cell carcinoma may also metastasize to the lung.
|
